Montica 4 mg (Chewable Tablet)

Unit Price: ৳ 7.00 (3 x 10: ৳ 210.00)
Strip Price: ৳ 70.00

Medicine Details

Category Details
Generic Montelukast sodium
Company Euro pharma ltd
Also available as
Montica 5 mg chewable tablet Montica 10 mg tablet

Title

  • Montica 4 mg Chewable Tablet

Categories

  • Medicine
  • Healthcare
  • Pharmaceutical

Description

  • Selective and orally active leukotriene receptor antagonist
  • Indicated for prophylaxis and chronic treatment of asthma
  • Used for acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relieves symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
  • Pharmacology: inhibits the cysteinyl leukotriene receptor (CysLT1)
  • Dosage: 10 mg tablet for adults, 5 mg tablet for pediatric patients (6-14 years), 4 mg tablet for pediatric patients (2-5 years)
  • Pediatric patients aged 6 months to 5 years: 4 mg oral granules once daily
  • Storage conditions: Store in cool & dry place below 30°C, protect from light & moisture
  • Therapeutic class: Leukotriene receptor antagonists
  • Commonly asked questions regarding usage and effects

Color Options

  • None

Dimensions

  • None

Functions

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction
  • Relief of symptoms of Allergic Rhinitis
  • Selective and orally active leukotriene receptor antagonist

Materials

  • Montelukast

Technical Specifications

  • Molecular Formula: C35H36ClNO3S
  • Chemical Structure: See image at provided URL

Design Elements

  • Chewable tablet form

Usability Features

  • Dosage suitable for pediatric and adult patients
  • No dosage adjustment required for mild-to-moderate hepatic insufficiency
  • No dosage adjustment recommended for renal insufficiency
  • Elderly use: No dosage adjustment required
  • Store in cool, dry place below 30°C, protect from light & moisture

Side Effects

  • Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
  • Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
  • Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor

Dosage & Administration

  • Adults and adolescents: 10 mg tablet once daily
  • Pediatric patients (6-14 years): 5 mg tablet once daily
  • Pediatric patients (2-5 years): 4 mg tablet once daily
  • Pediatric patients (6 months to 5 years): 4 mg oral granules once daily
  • Hepatic Insufficiency: No dosage adjustment required
  • Renal Insufficiency: No dosage adjustment recommended
  • Elderly use: No dosage adjustment required

Pregnancy & Lactation

  • Montelukast crosses the placenta following oral dosing in rats and rabbits
  • Use during pregnancy only if clearly needed
  • Caution advised when given to a nursing mother

Precautions & Warnings

  • Not indicated for use in the reversal of bronchospasm in acute asthma attacks
  • Have appropriate rescue medication available
  • Can be continued during acute exacerbations of asthma
  • Should not be abruptly substituted for inhaled or oral corticosteroids
  • Not to be used as monotherapy for the treatment and management of exercise induced bronchospasm
  • Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Montica

Interaction

  • Administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma
  • No clinically important effects on the pharmacokinetics of specified drugs at recommended clinical dose
  • Individual drug interaction studies not performed, but used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions

Contraindications

  • Hypersensitivity to any component of this product

Overdose Effects

  • No adverse experiences in the majority of overdosage reports
  • Adverse experiences consistent with the safety profile of Montica reported in the event of overdose
  • Usual supportive measures recommended in case of overdose

Storage Conditions

  • Store in cool & dry place below 30°C, protect from light & moisture, Keep out of reach of children

Related Brands